The Pathophysiology of Septic Shock

Critical Care Clinics

Volumn 25, Issue 4, 2009, Pages 677-702

  Nduka, O Okorie ^a,b   Parrillo, Joseph E ^c  

^a Department of Anesthesiology   (United States)

^b Altru Rehabilitation Center   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Myocardial depression; Sepsis; Septic shock; Severe sepsis; Vasodilation

Indexed keywords

CASPASE; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MACROPHAGE MIGRATION INHIBITION FACTOR; NITRIC OXIDE; PATTERN RECOGNITION RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; BACTERIAL GENETICS; BACTERIAL VIRULENCE; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; GENE EXPRESSION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; MICROORGANISM DETECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; QUORUM SENSING; REVIEW; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; VAGUS REFLEX;

GENE EXPRESSION; GENOMIC ISLANDS; HMGB PROTEINS; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; QUORUM SENSING; RECEPTORS, PATTERN RECOGNITION; RHO GTP-BINDING PROTEINS; SHOCK, SEPTIC; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; VIRULENCE FACTORS;

EID: 70350475286     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.08.002     Document Type: Review

References (64)

1. Geroulanos S., and Douka E.T. Historical perspective of the word "sepsis.". Intensive Care Med 32 (2006) 2077
2. Vincent J.L., and Abraham E. The last 100 years of sepsis. Am J Respir Crit Care Med 173 (2006) 256-263
3. Schottmueller H. Wesen und Behandlung der Sepsis [The nature and therapy of sepsis]. Inn Med 31 (1914) 257-280 [in German]
4. Cannon W.B. Traumatic shock (1923), D Appleton and Co, New York
5. Kumar A., and Parrillo J. Shock: classification, pathophysiology, and approach to management. In: Parillo J.E., and Dellinger R.P. (Eds). Critical care medicine: principles of diagnosis and management in the adult. 3rd edition (2008), Mosby Elsevier, Philadelphia 377-422
6. Campisi L., Brau F., and Glaichenhaus N. Imaging host-pathogen interactions. Immunol Rev 221 1 (2008) 188-199
7. Bassler B.L. Small talk. Cell-to-cell communication in bacteria. Cell 109 (2002) 421-424
8. Taga M.E., and Bassler B.L. Chemical communication among bacteria. Proc Natl Acad Sci U S A 100 Suppl 2 (2003) 14549-14554
9. Davies D.G., Parsek M.R., Pearson J.P., et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280 (1998) 295-298
10. Shiner E.K., Rumbaugh K.P., and Williams S.C. Inter-kingdom signaling: deciphering the language of acyl homoserine lactones. FEMS Microbiol Rev 29 (2005) 935-947
11. Hooi D.S., Bycroft B.W., Chhabra S.R., et al. Differential immune modulatory activity of Pseudomonas aeruginosa quorum-sensing signal molecules. Infect Immun 72 (2004) 6463-6470
12. Miller M.B., and Bassler B.L. Quorum sensing in bacteria. Annu Rev Microbiol 55 (2001) 165-199
13. Whiteley M., Lee K.M., and Greenberg E.P. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 96 (1999) 13904-13909
14. Cinel I., and Dellinger R.P. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 20 (2007) 345-352
15. van der Poll T., and Opal S.M. Host-pathogen interactions in sepsis. Lancet Infect Dis 8 (2008) 32-43
16. Creagh E.M., and O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27 (2006) 352-357
17. Granucci F., Foti M., and Ricciardi-Castagnoli P. Dendritic cell biology. Adv Immunol 88 (2005) 193-233
18. Uematsu S., and Akira S. Toll-like receptors and innate immunity. J Mol Med 84 (2007) 712-725
19. Mollen K.P., Anand R.J., Tsung A., et al. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26 (2006) 430-437
20. Paterson H.M., Murphy T.J., Purcell E.J., et al. Injury primes the innate immune system for enhanced toll-like receptor reactivity. J Immunol 171 (2003) 1473-1483
21. Arcaroli J., Fessler M.B., and Abraham E. Genetic polymorphisms and sepsis. Shock 24 (2005) 300-312
22. Gibot S., Cariou A., Drouet L., et al. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med 30 (2002) 969-973
23. Arcaroli J., Silva E., Maloney J.P., et al. Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 173 (2006) 1335-1341
24. Zaph C., Troy A.E., Taylor B.C., et al. Epithelial cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446 (2007) 552-556
25. Liu Y.J., Soumelis V., Watanabe N., et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 25 (2007) 193-219
26. Peck-Palmer O.M., Unsinger J., Chang K.C., et al. Deletion of MyD88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival. J Leukoc Biol 83 (2008) 1009-1018
27. Adib-Conquy M., Moine P., Asehnoune K., et al. Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am J Respir Crit Care Med 168 (2003) 158-164
28. Ayscough K.R., and Gourlay C.W. The actin cytoskeleton: a key regulator of apoptosis and aging. Nat Rev Mol Cell Biol 6 (2005) 583-589
29. Fischer U., Jänicke R.U., and Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10 1 (2003) 76-100
30. Sarkar A., Hall M.W., Exline M., et al. Caspase-1 regulates E. coli sepsis and splenic B cell apoptosis independently of IL-1[beta] and IL-18. Am J Respir Crit Care Med 174 (2006) 1003-1010
31. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
32. Nick J.A., Young S.K., Arndt P.G., et al. Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 MAP kinase. J Immunol 169 9 (2002) 5260-5269
33. Yum H.K., Arcaroli J., Kupfner J., et al. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol 167 11 (2001) 6601-6608
34. Ojaniemi M., Glumoff V., Harju K., et al. Phosphatidylinositol kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol 335 (2003) 597-605
35. Guillot L., Le Goffic R., Bloch S., et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 280 (2005) 5571-5580
36. Guha M., and Mackman N. The PI3K-Akt pathway limits LPS activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277 (2002) 32124-32132
37. Pengal R.A., Ganesan L.P., Wei G., et al. Lipopolysaccharide-induced production of interleukin-10 is promoted by the serin threonine kinase Akt. Mol Immunol 43 (2006) 1557-1564
38. Fukao T., and Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 24 (2003) 358-363
39. Maus U.A., Backi M., Winter C., et al. Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection. Am J Respir Crit Care Med 175 9 (2007) 958-966
40. Hall A., and Rho G.T. Pases and the actin cytoskeleton. Science 279 (1998) 509-514
41. Ruse M., and Knaus U.G. New players in TLR-mediated innate immunity. Immunol Res 34 (2006) 33-48
42. Arbibe L., Mira J.P., Teusch N., et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Racl dependent pathway. Nat Immunol 1 (2000) 533-554
43. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003) 138-150
44. Rapaport S.I., Tatter D., and Coeur-Baron N. Pseudomonas septicemia with intravascular clotting leading to the generalized Shwartzman reaction. N Engl J Med 271 (1964) 80
45. Corrigan J.J., Ray W.L., and May N. Changes in the blood coagulation system associated with septicemia. N Engl J Med 279 (1968) 851-856
46. Beller F.K. The role of endotoxin in disseminated intravascular coagulation. Thromb Diath Haemorrh Suppl 36 (1969) 125-149
47. Corrigan J.J., and Jordan C.M. Heparin therapy in septicemia with disseminated intravascular coagulation. N Engl J Med Shock 283 (1970) 778-782
48. Bernik T.R., Friedman S.G., Ochani M., et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 195 (2002) 781-788
49. Borovikova L.V., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
50. Altavilla D., Guarini S., Bitto A., et al. Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects against splanchic artery occlusion shock. Shock 25 (2006) 500-506
51. Huston J.M., Ochani M., Rosas-Ballina M., et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203 (2006) 1623-1628
52. Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
53. Wang H., Liao H., Ochani M., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10 (2004) 1216-1221
54. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117 (2007) 289-296
55. Flierl M.A., Rittirsch D., Nadeau B.A., et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449 (2007) 721-725
56. Annane D., de la Grandmaison G., Brouland J.P., et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med 160 (1999) 458-465
57. Calvin J.E., Driedger A.A., and Sibbald W.J. An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest 80 (1981) 579-586
58. Parker M.M., McCarthy K.E., Ognibene F.P., et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97 (1990) 126-131
59. Munt B., Jue J., Gin K., et al. Diastolic filling in human severe sepsis: an echocardiographic study. Crit Care Med 26 (1998) 1829-1833
60. Poelaert J., Declerck C., Vogelaers D., et al. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 23 (1997) 553-560
61. Parker M.M., Shelhamer J.H., Natanson C., et al. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15 (1987) 923-929
62. Parrillo J.E., Burch C., Shelhamer J.H., et al. A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 76 (1985) 1539-1553
63. Kumar A., Thota V., Dee L., et al. Tumor necrosis factor-alpha and interleukin-1 beta are responsible for depression of in vitro myocardial cell contractility induced by serum from humans with septic shock. J Exp Med 183 (1996) 949-958
64. Ullrich R., Scherrer-Crosbie M., Bloch K.D., et al. Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation 102 (2000) 1440-1446